GLP-1 Drugs and Sleep Apnea — A Breakthrough? cover art

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

Written by: Inception Point Ai
Listen for free

About this listen

 Discover how tirzepatide became the first FDA-approved drug for obstructive sleep apnea, offering hope to millions struggling with CPAP machines. Julia Cartwright investigates the science, patient experiences, and clinical implications of this breakthrough treatment that goes far beyond simple weight loss.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai
Episodes
  • GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story

    GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story
    Apr 7 2026
    Host Julia Cartwright explores groundbreaking research on GLP-1 drugs and sleep apnea, revealing how medications like tirzepatide work beyond weight loss through brain receptors, anti-inflammatory effects, and metabolic improvements. Drawing on SURMOUNT-OSA trials and emerging science, she explains why these multi-pathway treatments are revolutionizing our understanding of obstructive sleep apnea as a whole-body condition.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    25 mins
  • GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story

    GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story
    Apr 7 2026
    Host Julia Cartwright explores groundbreaking research on GLP-1 drugs and sleep apnea, revealing how medications like tirzepatide work beyond weight loss through brain receptors, anti-inflammatory effects, and metabolic improvements. Drawing on SURMOUNT-OSA trials and emerging science, she explains why these multi-pathway treatments are revolutionizing our understanding of obstructive sleep apnea as a whole-body condition.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    25 mins
No reviews yet